Compare uniQure N.V. Ordinary Shares (QURE) vs Invesco Solar ETF (TAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Invesco Solar ETF — how do they compare? uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B), while Invesco Solar ETF trades at $42.4 (market cap $881.52M). The key difference: uniQure N.V. Ordinary Shares is the larger of the two by market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Invesco Solar ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Invesco Solar ETF for 35 Days on average.
| QURE | TAN | |
|---|---|---|
Market Cap | $1.48B | $881.52M |
Volume | 2,488,780 | 3,915,267 |
Sector | Health | Sector/Thematic |
52-Week High | $70.59 | $73.95 |
52-Week Low | $9.03 | $42.64 |
Typical Hold Time | 0 Days | 35 Days |
Enterprise Value | $728.62M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TAN trades at $44.38, up 2.07% today but facing bearish technical signals with sell signals outweighing buys 11-8. The solar ETF shows mixed sentiment amid sector volatility, with recent news highlighting both policy tailwinds from U.S. tariffs and headwinds from high borrowing costs impacting project financing.
Outlook remains cautious due to sector-specific risks including interest rate sensitivity and market saturation concerns. While geopolitical shifts favor renewable energy adoption, TAN's high expense ratio and historical underperformance versus broad market indices present challenges for investors seeking stable returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Invesco Solar ETF
TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →
